Opioids in the New Era
Chronic intractable pain patients frequently encounter insurmountable system resistance in their attempt to obtain pain relief. This activity is meant to illustrate the potential benefit of appropriate opioid prescribing for a carefully selected and monitored subgroup of intractable pain patients as well as the risks associated with prescription use. Revised CDC and MEB guidelines will assist PCPs as well as all Providers with updated information to address the opioid epidemic. CDC data from 2011 to 2015 shows the United States contains 5% of the world population however we consume 80% of the world's opiates.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Medical College of Wisconsin and Advanced Pain Management. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 4.5 hours of participation for continuing education for allied health professionals.
Allied Health Care Providers
- Outline the role of licensure board in influencing licensee's clinical performance regarding opioids
- Embrace their role as promoter of public health with respect to opioids' safe use
- Understand and implement revised CDC and MEB guidelines for improvement in patient care
- 4.50 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 4.50 Hours of ParticipationHours of Participation credit.